CompareMarketResearchRequest a sample
Home / Food and Beverage / Gastrointestinal Surgery Nutrition

Food and Beverage · Market report

Gastrointestinal Surgery Nutrition Market Size, Share and Forecast 2026-2036

The global gastrointestinal surgery nutrition market is worth USD 763 mn in 2026 and is forecast to reach USD 1.4 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Immunonutrition drinks is the largest by product segment.

USD 763 mnMarket size 2026
USD 1.4 bnForecast 2036
6.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global gastrointestinal surgery nutrition market is worth USD 763 mn in 2026 and is forecast to reach USD 1.4 bn by 2036, growing at a 6.0% CAGR. United States is the largest country market and Immunonutrition drinks is the largest by product segment.

ScopeOral and tube-fed nutrition used before and after stomach, bowel and other digestive surgery: immunonutrition drinks, pre-operative carbohydrate drinks, recovery supplements and enteral formulas.
IndustryFood and Beverage
Value 2025USD 720 mn
Value 2026USD 763 mn
Value 2036USD 1.4 bn
CAGR 2026-20366.0%
Volume 202694.5 million units
Volume 2036153 million units
Average price 2026USD 8.08 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Gastrointestinal Surgery Nutrition market size and forecast, 2026-2036

Exhibit 1The global gastrointestinal surgery nutrition market is forecast to grow from USD 763 mn in 2026 to USD 1.4 bn by 2036, a rise of 79%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.0%
Gastrointestinal Surgery Nutrition market value, 2025 to 2036Market value by year. 2025: USD 720.0 mn; 2026: USD 763.2 mn; 2027: USD 809.0 mn; 2028: USD 857.5 mn; 2029: USD 909.0 mn; 2030: USD 963.5 mn; 2031: USD 1.02 bn; 2032: USD 1.08 bn; 2033: USD 1.15 bn; 2034: USD 1.22 bn; 2035: USD 1.29 bn; 2036: USD 1.37 bn. Compound annual growth rate 2026 to 2036: 6.0%.2025763.2 mn20261.02 bn20311.37 bn20366.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 763.2 mn
2027USD 809.0 mn
2028USD 857.5 mn
2029USD 909.0 mn
2030USD 963.5 mn
2031USD 1.02 bn
2032USD 1.08 bn
2033USD 1.15 bn
2034USD 1.22 bn
2035USD 1.29 bn
2036USD 1.37 bn

Gastrointestinal Surgery Nutrition market segmentation

By product

Exhibit 2Immunonutrition drinks is the largest segment by product, with 34.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Gastrointestinal Surgery Nutrition market share by product, 2026Share of 2026 revenue by product. Immunonutrition drinks: 34.0%; Post-operative oral supplements: 28.0%; Enteral tube feeds: 20.0%; Pre-operative carbohydrate drinks: 18.0%.Immunonutrition drinks34.0%Post-operative oral supplements28.0%Enteral tube feeds20.0%Pre-operative carbohydrate drinks18.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Immunonutrition drinks34.0%34.3%USD 259 mn6.1%
Pre-operative carbohydrate drinks18.0%19.9%USD 137 mn7.1%
Post-operative oral supplements28.0%25.7%USD 214 mn5.1%
Enteral tube feeds20.0%20.2%USD 153 mn6.1%

By setting

Exhibit 3Hospitals adds the most revenue by setting, growing from USD 504 mn in 2026 to USD 867 mn by 2036Estimated revenue in USD by setting, 2026 and 2036 forecast
Gastrointestinal Surgery Nutrition market by setting, 2026 and 2036Revenue by setting in 2026 and 2036. Hospitals: USD 504 mn in 2026, USD 867 mn in 2036, change +72%; Outpatient and home recovery: USD 168 mn in 2026, USD 349 mn in 2036, change +108%; Long-term care: USD 92 mn in 2026, USD 150 mn in 2036, change +64%.20262036 forecastChangeHospitals+72%504 mn867 mnOutpatient and home recovery+108%168 mn349 mnLong-term care+64%92 mn150 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals66.0%63.5%USD 504 mn5.6%
Outpatient and home recovery22.0%25.5%USD 168 mn7.6%
Long-term care12.0%11.0%USD 92 mn5.1%

By surgery type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Colorectal34.0%33.0%USD 259 mn5.7%
Gastric and upper GI28.0%28.0%USD 214 mn6.0%
Pancreatic and liver20.0%20.0%USD 153 mn6.0%
Bariatric18.0%19.0%USD 137 mn6.6%

By patient group

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Adults below 6548.0%44.0%USD 366 mn5.1%
Older adults44.0%48.0%USD 336 mn6.9%
Paediatric8.0%8.0%USD 61 mn6.0%

By funding source

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Public health systems58.0%55.0%USD 443 mn5.4%
Private insurance26.0%27.0%USD 198 mn6.4%
Out of pocket16.0%18.0%USD 122 mn7.3%

Top 25 countries for gastrointestinal surgery nutrition by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.5% of 2026 revenue and the 25 countries below together hold 95.4%.

Exhibit 4United States is the largest country market at USD 206 mn in 2026, and the three largest countries hold 46.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Gastrointestinal Surgery Nutrition market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 206 mn, 27.0%; Germany: USD 76 mn, 10.0%; Japan: USD 69 mn, 9.0%; China: USD 61 mn, 8.0%; France: USD 53 mn, 7.0%; United Kingdom: USD 46 mn, 6.0%; Italy: USD 38 mn, 5.0%; Spain: USD 31 mn, 4.0%; Netherlands: USD 27 mn, 3.5%; Australia: USD 23 mn, 3.0%.United States206 mn 27.0%Germany76 mn 10.0%Japan69 mn 9.0%China61 mn 8.0%France53 mn 7.0%United Kingdom46 mn 6.0%Italy38 mn 5.0%Spain31 mn 4.0%Netherlands27 mn 3.5%Australia23 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 206 mn27.0%USD 364 mn5.8%
2GermanyUSD 76 mn10.0%USD 123 mn4.9%
3JapanUSD 69 mn9.0%USD 111 mn4.9%
4ChinaUSD 61 mn8.0%USD 149 mn9.3%
5FranceUSD 53 mn7.0%USD 90 mn5.4%
6United KingdomUSD 46 mn6.0%USD 77 mn5.3%
7ItalyUSD 38 mn5.0%USD 64 mn5.3%
8SpainUSD 31 mn4.0%USD 53 mn5.7%
9NetherlandsUSD 27 mn3.5%USD 45 mn5.4%
10AustraliaUSD 23 mn3.0%USD 42 mn6.3%
11South KoreaUSD 15 mn2.0%USD 31 mn7.3%
12CanadaUSD 11 mn1.4%USD 17 mn4.8%
13BrazilUSD 8.9 mn1.2%USD 18 mn7.3%
14IndiaUSD 7.7 mn1.0%USD 20 mn9.8%
15PolandUSD 6.9 mn0.9%USD 14 mn7.4%
16SwedenUSD 6.3 mn0.8%USD 10.0 mn4.8%
17BelgiumUSD 5.8 mn0.8%USD 9.3 mn4.8%
18SwitzerlandUSD 5.4 mn0.7%USD 8.6 mn4.7%
19AustriaUSD 5.1 mn0.7%USD 8.2 mn4.8%
20TurkeyUSD 4.9 mn0.6%USD 9.8 mn7.3%
21RussiaUSD 4.7 mn0.6%USD 6.3 mn3.0%
22TaiwanUSD 4.4 mn0.6%USD 7.1 mn4.8%
23MexicoUSD 4.3 mn0.6%USD 8.8 mn7.4%
24Saudi ArabiaUSD 4.1 mn0.5%USD 8.3 mn7.3%
25DenmarkUSD 4.0 mn0.5%USD 6.3 mn4.7%
Rest of worldUSD 35 mn4.6%USD 66 mn6.6%
Exhibit 5United States and China account for 41% of the USD 604 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Gastrointestinal Surgery Nutrition market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 763 mn. United States: +USD 158 mn; China: +USD 88 mn; Germany: +USD 47 mn; Japan: +USD 42 mn; France: +USD 37 mn; 20 other countries: +USD 202 mn; Rest of world: +USD 31 mn. Market value 2036: USD 1.4 bn.Market value 2026763 mnUnited States+158 mnChina+88 mnGermany+47 mnJapan+42 mnFrance+37 mn20 other countries+202 mnRest of world+31 mnMarket value 20361.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Nestlé Health Science
  • Abbott
  • Nutricia
  • Fresenius Kabi

Group 2: Regional and specialist players

  • Meiji Holdings
  • Terumo
  • B. Braun
  • Ajinomoto
  • Otsuka Pharmaceutical Factory
  • Morinaga Milk

Group 3: Emerging and niche players

  • Kate Farms
  • Real Food Blends
  • Vegenat
  • Nualtra

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the gastrointestinal surgery nutrition market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.

The market is divided by product, by setting, by surgery type, by patient group, by funding source. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the gastrointestinal surgery nutrition market?

The global gastrointestinal surgery nutrition market is estimated at USD 720 mn in 2025 and USD 763 mn in 2026.

How fast will the gastrointestinal surgery nutrition market grow?

It is forecast to reach USD 1.4 bn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 604 mn.

Which country is the largest market for gastrointestinal surgery nutrition?

United States is the largest market by revenue at USD 206 mn in 2026, 27.0% of the global total. The three largest countries together hold 46.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 9.3% a year from 2026 to 2036.

Which gastrointestinal surgery nutrition segment is largest?

In the by product split, Immunonutrition drinks is the largest segment with 34.0% of 2026 revenue.

Who are the leading gastrointestinal surgery nutrition companies?

Global leaders include Nestlé Health Science, Abbott, Nutricia, Fresenius Kabi.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Food and Beverage

← Functional Fruit Leathers Gelatin →

All Food and Beverage markets →

Request a sample